Insulet ROA 2007-2018 | PODD

Current and historical return on assets (ROA) values for Insulet (PODD) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Insulet ROA for the three months ending September 30, 2018 was -1.60%.
Insulet ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.01B $0.89B -1.66%
2018-06-30 $-0.02B $0.84B -2.41%
2018-03-31 $-0.02B $0.83B -3.68%
2017-12-31 $-0.03B $0.82B -4.86%
2017-09-30 $-0.03B $0.50B -6.23%
2017-06-30 $-0.03B $0.46B -6.62%
2017-03-31 $-0.03B $0.45B -6.43%
2016-12-31 $-0.03B $0.46B -7.84%
2016-09-30 $-0.05B $0.45B -14.77%
2016-06-30 $-0.06B $0.26B -22.84%
2016-03-31 $-0.07B $0.26B -26.00%
2015-12-31 $-0.07B $0.28B -24.87%
2015-09-30 $-0.05B $0.29B -17.06%
2015-06-30 $-0.04B $0.30B -14.29%
2015-03-31 $-0.06B $0.31B -18.55%
2014-12-31 $-0.05B $0.30B -16.83%
2014-09-30 $-0.05B $0.30B -16.29%
2014-06-30 $-0.06B $0.33B -19.82%
2014-03-31 $-0.04B $0.29B -14.24%
2013-12-31 $-0.05B $0.29B -16.08%
2013-09-30 $-0.05B $0.29B -20.11%
2013-06-30 $-0.04B $0.29B -18.18%
2013-03-31 $-0.05B $0.28B -21.22%
2012-12-31 $-0.05B $0.20B -24.85%
2012-09-30 $-0.06B $0.20B -26.07%
2012-06-30 $-0.06B $0.20B -26.60%
2012-03-31 $-0.05B $0.22B -23.21%
2011-12-31 $-0.05B $0.22B -22.66%
2011-09-30 $-0.05B $0.22B -28.38%
2011-06-30 $-0.05B $0.23B -29.96%
2011-03-31 $-0.06B $0.15B -36.95%
2010-12-31 $-0.06B $0.16B -38.92%
2010-09-30 $-0.06B $0.15B -34.78%
2010-06-30 $-0.06B $0.16B -39.93%
2010-03-31 $-0.07B $0.16B -48.91%
2009-12-31 $-0.07B $0.17B -57.37%
2009-09-30 $-0.09B $0.12B -77.48%
2009-06-30 $-0.09B $0.10B -78.79%
2009-03-31 $-0.10B $0.12B -73.36%
2008-12-31 $-0.10B $0.11B -73.93%
2008-09-30 $-0.08B $0.14B -61.08%
2008-06-30 $-0.07B $0.16B -55.02%
2008-03-31 $-0.06B $0.12B -47.37%
2007-12-31 $-0.06B $0.13B -47.41%
2007-09-30 $-0.05B $0.14B -51.28%
2007-06-30 $-0.05B $0.15B -70.87%
2007-03-31 $-0.04B $0.05B -156.19%
2006-12-31 $-0.04B $0.06B -252.63%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.012B $0.464B
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.916B 25.68
Medtronic (MDT) Ireland $122.526B 18.32
Stryker (SYK) United States $69.144B 25.38
Boston Scientific (BSX) United States $55.241B 26.97
Baxter (BAX) United States $38.548B 23.75
Zimmer Biomet Holdings (ZBH) United States $24.985B 16.03
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
ResMed (RMD) United States $14.250B 27.02
Canopy Growth (CGC) Canada $10.707B 0.00
Bio-Rad Laboratories (BIO) United States $7.832B 50.08
Aurora Cannabis (ACB) Canada $7.090B 50.71
Hill-Rom Holdings (HRC) United States $6.904B 21.35
Perrigo (PRGO) Ireland $6.603B 10.02
ICU Medical (ICUI) United States $5.119B 28.52
GW Pharmaceuticals (GWPH) United Kingdom $4.563B 0.00
Haemonetics (HAE) United States $4.395B 38.99
Agios Pharmaceuticals (AGIO) United States $3.341B 0.00
Hutchison China MediTech (HCM) China $3.330B 0.00
Neogen (NEOG) United States $3.259B 50.06
NuVasive (NUVA) United States $3.008B 27.99
National Vision Holdings (EYE) United States $2.570B 49.72
Quidel (QDEL) United States $2.529B 22.88
Aphria (APHA) $2.274B 101.00
NxStage Medical (NXTM) United States $1.945B 0.00
AtriCure (ATRC) United States $1.269B 0.00
VAREX IMAGING (VREX) United States $1.196B 23.42
Phibro Animal Health (PAHC) United States $1.192B 17.13
Cardiovascular Systems (CSII) United States $1.151B 826.00
HEXO (HEXO) $1.127B 0.00
MacroGenics (MGNX) United States $0.893B 0.00
Cerus (CERS) United States $0.848B 0.00
PetIQ (PETQ) United States $0.821B 21.28
Evolus (EOLS) United States $0.744B 0.00
Surmodics (SRDX) United States $0.724B 105.35
NanoString Technologies (NSTG) United States $0.721B 0.00
Lantheus Holdings (LNTH) United States $0.711B 22.00
OraSure Technologies (OSUR) United States $0.707B 31.19
Omeros (OMER) United States $0.703B 0.00
Meridian Bioscience (VIVO) United States $0.698B 20.80
Eagle Pharmaceuticals (EGRX) United States $0.604B 19.39
Quanterix (QTRX) United States $0.491B 0.00
LeMaitre Vascular (LMAT) United States $0.486B 23.89
Owens & Minor (OMI) United States $0.470B 5.32
TG Therapeutics (TGTX) United States $0.390B 0.00
Insys Therapeutics (INSY) United States $0.355B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.98
BioLife Solutions (BLFS) United States $0.285B 385.00
Bovie Medical (APYX) United States $0.283B 0.00
Vapotherm (VAPO) United States $0.279B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.272B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.228B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.152B 0.00
Fonar (FONR) United States $0.147B 7.87
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.11
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.079B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.53
Conatus Pharmaceuticals (CNAT) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Neurotrope (NTRP) United States $0.033B 0.00
Senestech (SNES) United States $0.020B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14